Regulation of cancer stem cells in triple negative breast cancer

Area of Science:

• Oncology
• Cancer Biology
• Genomics

Background:

• Triple Negative Breast Cancer (TNBC) is the most lethal breast cancer subtype.
• High rates of relapse, recurrence, and therapy failure in TNBC compared to other subtypes.
• Therapy-resistant Cancer Stem Cell (CSC) populations are implicated in poor TNBC outcomes and are enriched in TNBC.

Purpose of the Study:

• To focus on TNBC-specific mechanisms driving Cancer Stem Cell (CSC) expansion and self-renewal.
• To highlight cellular signaling pathways and transcription factors enriched in TNBC that contribute to stemness.
• To explore the potential of bioinformatic approaches, like single-cell RNA-seq, in identifying novel stemness drivers in TNBC.

Main Methods:

• Literature review focusing on TNBC-specific CSC mechanisms.
• Analysis of cellular signaling pathways and transcription factors.
• Bioinformatic analysis of publicly available single-cell RNA-seq data from basal breast cancer tumors.

Main Results:

• TNBC exhibits unique mechanisms for CSC expansion and activity compared to other breast cancers.
• Specific signaling pathways and transcription factors are identified as key drivers of stemness in TNBC.
• Single-cell RNA-seq data analysis reveals potential novel drivers of stemness.

Conclusions:

• Understanding TNBC-specific CSC mechanisms is crucial for improving treatment outcomes.
• Targeting identified pathways and factors could lead to novel therapeutic strategies for TNBC.
• Bioinformatic approaches show promise in uncovering new targets for TNBC and other cancers.